Indian generic drug giant Aurobindo Pharma announced on Friday that it is on the verge of pulling off a major expansion in the United States after clearing a critical regulatory hurdle.
The Hyderabad-based pharmaceutical heavyweight said that it has secured antitrust clearance from the US Federal Trade Commission (FTC) for its impending takeover of American drugmaker Lannett Company.